Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan.
J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3121-e3133. doi: 10.1210/clinem/dgac319.
Children born small-for-gestational-age with short stature (SGA-SS) is associated with (epi)genetic defects, including imprinting disorders (IDs), pathogenic copy number variants (PCNVs), and pathogenic variants of genes involved in growth. However, comprehensive studies evaluating these 3 factors are very limited.
To clarify the contribution of PCNVs and candidate pathogenic variants to SGA-SS.
Comprehensive molecular analyses consisting of methylation analysis, copy number analysis, and multigene sequencing.
We enrolled 140 patients referred to us for genetic testing for SGA-SS. Among them, we excluded 42 patients meeting Netchine-Harbison clinical scoring system criteria for Silver-Russell syndrome and 4 patients with abnormal methylation levels of the IDs-related differentially methylated regions. Consequently, we conducted copy number analysis and multigene sequencing for 86 SGA-SS patients with sufficient sample volume. We also evaluated clinical phenotypes of patients with PCNVs or candidate pathogenic variants.
We identified 8 (9.3%) and 11 (12.8%) patients with PCNVs and candidate pathogenic variants, respectively. According to the American College of Medical Genetics standards and guidelines, 5 variants were classified as pathogenic and the remaining 6 variants were classified as variants of unknown significance. Genetic diagnosis was made in 12 patients. All patients with PCNVs or candidate pathogenic variants did not correspond perfectly to characteristic clinical features of each specific genetic cause.
We clarified the contribution of PCNVs and pathogenic variants to SGA-SS without IDs. Comprehensive molecular analyses, including copy number analysis and multigene sequencing, should be considered for patients with unknown SGA-SS etiology.
伴有身材矮小的出生小样儿(SGA-SS)与(表观)遗传缺陷相关,包括印迹缺陷(IDs)、致病性拷贝数变异(PCNVs)和与生长相关的基因的致病性变异。然而,全面评估这 3 个因素的研究非常有限。
阐明 PCNVs 和候选致病性变异对 SGA-SS 的贡献。
包括甲基化分析、拷贝数分析和多基因测序的综合分子分析。
我们纳入了 140 名因 SGA-SS 接受遗传检测的患者。其中,我们排除了 42 名符合 Netchine-Harbison 临床评分系统中 Silver-Russell 综合征标准的患者和 4 名 IDs 相关差异甲基化区域甲基化水平异常的患者。因此,我们对 86 名具有足够样本量的 SGA-SS 患者进行了拷贝数分析和多基因测序。我们还评估了具有 PCNVs 或候选致病性变异的患者的临床表型。
我们分别发现了 8 名(9.3%)和 11 名(12.8%)患者存在 PCNVs 和候选致病性变异。根据美国医学遗传学学院的标准和指南,5 个变异被归类为致病性,其余 6 个变异被归类为意义不明的变异。在 12 名患者中做出了遗传诊断。所有具有 PCNVs 或候选致病性变异的患者的临床特征与每种特定遗传病因的特征并不完全相符。
我们阐明了 PCNVs 和致病性变异对无 IDs 的 SGA-SS 的贡献。对于病因不明的 SGA-SS 患者,应考虑进行包括拷贝数分析和多基因测序在内的综合分子分析。